Vinn,
Excellent post and what a progressive coy to be partnership with.
TEVA's no 1 selling drug is its $3 billion multiple sclerosis(MS) drug Copaxone which currently makes up 21% of sales(coming off patent in 2013). So TEVAs acquisition of CEPH now has the merged entity @ $20bn - talk about forward planning by this super Global Pharma.
And if the Cardio Franshise wanst enough, just to make sure that MSB retains its NO 1 'sweetheart' title within the TEVA family, the Blaster is looking at developing an MS application as part of its Intravenous Program /Francshise ( page 5 annual report).
Great 2012 coming on !
Cheers to all holders.
- Forums
- ASX - By Stock
- MSB
- this company is now a substantial holder ....
this company is now a substantial holder ...., page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10425 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 44243 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10425 | 1.440 |
2 | 9000 | 1.435 |
4 | 62190 | 1.430 |
1 | 473 | 1.425 |
1 | 5000 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 16999 | 2 |
1.455 | 17000 | 1 |
1.465 | 24896 | 3 |
1.470 | 112738 | 6 |
1.475 | 1800 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |